Head-to-head for women
SkinnyRx vs yourEra
SkinnyRx and yourEra both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
SkinnyRx
Ranked #51 for women · Grade C
Luna Fit
Best for: Readers treating insulin resistance who want the dual GIP/GLP-1 molecule without a weekly injection, and who will open the plan selector and read the month-to-month rate rather than the advertised one.
FDA warning letterFebruary 2026Read it ↗Visit SkinnyRxyourEra
Higher scoreRanked #3 for women · Grade B
Luna Fit
Best for: Women who want transparently priced semaglutide and tirzepatide plus an optional NAD+, microdosing, and coaching-and-labs menu on one account.
Visit yourEraThe verdict for women
yourEra edges out SkinnyRx on the Luna Fit Score, 86 to 71 (B vs C). Women who want transparently priced semaglutide and tirzepatide plus an optional NAD+, microdosing, and coaching-and-labs menu on one account. The reasoning behind that number is in our full yourEra review.
SkinnyRx is still a genuine option — the rare program that compounds tirzepatide as a dissolving tablet as well as an injection — genuinely useful if the needle is what is stopping you — sold behind a four-rung commitment ladder whose cheapest rung is the only price the site ever shows you. Weigh the six women's-health factors below against your own priorities; the SkinnyRx scorecard goes through each of them, and if neither of these two is the one, our ranked shortlist of SkinnyRx alternatives widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | SkinnyRx | yourEra |
|---|---|---|
| Luna Fit Score | 71/100 · C | 86/100 · B |
| Overall rank | #51 | #3 |
| Semaglutide | $349/mo month-to-month (from $199/mo on a 12-month plan) — the site displays only the 12-month rate | $199/mo |
| Tirzepatide | $399/mo month-to-month, injectable or dissolving tablet (from $299/mo on a 12-month plan) — the site displays only the 12-month rate | $299/mo |
| Coverage | No state list published; the offer terms report no state restrictions | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Yes | Injection only |
Luna Fit
SkinnyRx
Ranked #51 · Grade C
What we like
- A compounded tirzepatide TABLET — a dissolving sublingual route for the dual GIP/GLP-1 molecule, priced identically to the injection at every rung, which is close to unique in this ranking
- Both molecules across three routes — injection, sublingual and daily tablet — so needle aversion never means changing provider or dropping back to the single-pathway drug
- Lower-dose "microdose" lines for both molecules are sold as their own products with their own published ladders, rather than being quoted at the full-dose price
The caveats
- Carries an active FDA warning letter issued in February 2026 (see the notice on this page for FDA's own record)
- Every price the site advertises is the TWELVE-MONTH rung: its own headline reads "Starting at $299/mo" while the month-to-month tirzepatide rate is $399 and the renewal price in its code is literally 399 — semaglutide is the same shape at $199 advertised against $349 month-to-month
- The commitment is not named beside the number anywhere in the marketing copy, and the prepay rung is also what its schema.org product markup publishes as the price — so search engines and AI assistants are given the twelve-month rate as though it were the monthly one
Luna Fit
yourEra
Ranked #3 · Grade B
What we like
- Publicly listed pricing on both molecules — semaglutide from $199/mo and tirzepatide from $299/mo — while many compounders hide price behind a quiz
- Fuller menu beyond GLP-1: NAD+ and microdosing protocols, plus an optional membership adding 1:1 coaching, a nutritionist, and an at-home lab draw
- Markets a 50-state licensed-clinician network, no insurance required, with HSA/FSA accepted
The caveats
- Compounded semaglutide and tirzepatide are not FDA-approved the way brand Wegovy, Ozempic, or Zepbound are, and compounding access can tighten as brand shortages resolve
- Mid-market pricing that sits above the cheapest compounders (roughly $99–$150)
- Injectable only — no oral route and no brand-name lane
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither SkinnyRx nor yourEra is only worth comparing with the other. SkinnyRx is also written up against CoreAge Rx, 22 points apart on the Luna Fit Score — see the SkinnyRx–CoreAge Rx head-to-head. yourEra is also written up against CoreAge Rx, 7 points apart — see how yourEra and CoreAge Rx compare on the Luna Fit Score.
- SkinnyRx vs CoreAge Rx
- SkinnyRx vs Enhance MD
- SkinnyRx vs Sesame Care
- yourEra vs HealthRX
- yourEra vs MadeMed
- yourEra vs Trimi
Or browse the full comparison hub.